1. Thematic Areas
  2. Polio eradication
  3. WHO Poliomyelitis eradication program: Selected References

WHO Poliomyelitis eradication program: Selected References

  • Adams A, Salisbury DM. Editorial. Eradicating polio. Science 2015;330 (6261): 609.
  • Previsani N, Tangermann RH, Tallis G, Jafari HS. World Health Organization Guidelines for Containment of Poliovirus Following Type-Specific Polio Eradication- Worldwide. MMWR Morb Mortal Wkly Rep 2015;64:913-917.
  • Del Casino VJ, Butterworth M, Davis G. The slippery geographies of polio. Lancet, 2014, 14: 546-547.
  • Nyewale V. Out of the dangerous wild, but not yet out of woods - The polio end game strategy. Indian Pediatrics, 2014, 51: 347-348.
  • Butler D. Polio risk looms over Europe. Cases in Syria highlight vulnerability of nearby countries to the viral disease. Nature. 2013, 502: 601-602.
  • Branswell H. The hidden threat that could prevent Polio's global eradication. Polio could soon be wiped out - but only if scientists can track down the last carriers. Nature. 2013, doi: 10.1038/nature.2013.13557 (This paper was originally published by Scientific American on 13 August 2013).
  • Callaway E. Polio's moving target. Finding and vaccinating Nigerian nomads may be one of the last obstacles to the eradication of polio. Nature. 2013, 496: 290.
  • Callaway E. Vaccine switch urged for polio endgame. Inactivated virus vaccine could deliver the final blow. Nature. 2013, 493: 285.
  • A war not yet won. The eradication of polio is within reach, but it is too early for self-congratulation. In This Week Editorials, Nature. 2012, 485: 547-548.
  • Nathanson N, Kew OM. From emergence to eradication: The epidemilogy of poliomyelitis deconstructed. Am J Epidemiol. 2010, 172 (11): 1213-1229.
  • Modlin JF. The bumpy road to polio eradication. N Engl J Med. 2010, 362 (25): 2346-2349.
  • Roberts L. Polio eradication: Looking for a Little Luck. Science. 2009, 323 (5915): 702-705.
  • Arita I, Nakane M. Road map for polio eradication - establishing the link with Millennium Development Goal no. 4 for child survival. Jpn J Infect Dis. 2008, 61 (3): 169-74.
  • Nathanson N. Chapter 1 the pathogenesis of poliomyelitis: what we don't know. Adv Virus Res. 2008, 71: 1-50.
  • Collett MS, Neyts J, Modlin JF. A case for developing antiviral drugs against polio. Antiviral Res. 2008 May 13.
  • Thompson KM, Tebbens RJ, Pallansch MA, Kew OM, Sutter RW, Aylward RB, Watkins M, Gary HE Jr, Alexander J, Jafari H, Cochi SL. The risks, costs, and benefits of possible future global policies for managing polioviruses. Am J Public Health. 2008, 98 (7): 1322-30.
  • Centers for Disease Control and Prevention (CDC). Progress Toward Interruption of Wild Poliovirus Transmission Worldwide, January 2007-April 2008. MMWR Morb Mortal Wkly Rep. 2008,57 (18): 489-494.
  • De Palma AM, Pürstinger G, Wimmer E, Patick AK, Andries K, Rombaut B, et al. Potential use of antiviral agents in polio eradication. Emerg Infect Dis. 2008, 14 (4): 545-551.
  • Thys B, De Palma AM, Neyts J, Andries K, Raf Vrijsen R, Bart Rombaut B. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond. Antiviral Research. 2008, 78 (3): 278-281.
  • Butcher J. Polio eradication nears the end game. Lancet Neurology. 2008, 7 (4) : 292-293.
  • Khan MM. Economics of polio vaccination in the post-eradication era: Should OPV-using countries adopt IPV? Vaccine. 2008, 26 (16): 2034-40.
  • Reynolds T. Polio: An end in sight? BMJ - Infectious diseases- 2007, 335 : 852-4.
  • Centers for Disease Control and Prevention (CDC). Update on vaccine-derived polioviruses worldwide, January 2006-August 2007. MMWR Morb Mortal Wkly Rep. 2007, 56 (38): 996-1001.
  • Chumakov K, Ehrenfeld E, Wimmer E & Agol VI. Vaccination against polio should not be stopped. Nat Rev Microbiol. 2007, 5 (12): 952-8.
  • Lahariya C. Global eradication of polio: the case for "finishing the job". Bull World Health Organ 2007, 85(6): 487-92.
  • Dowdle W, van der Avoort H, de Gourville E, Delpeyroux F, Desphande J, Hovi T, Martin J, Pallansch M, Kew O & Wolff C. Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management. Risk Anal. 2006 26(6): 1449-69.
  • Martín J. Vaccine-derived poliovirus from long term excretors and the end game of polio eradication. Biologicals. 2006, 34 (2): 117-22.
  • Bruce Aylward R, Sutter RW, Cochi SL, Thompson KM, Jafari H & Heymann D. Risk management in a polio-free world. Risk Anal. 2006, 26(6): 1441-8.
  • Heymann DL, Sutter RW & Aylward RB. A vision of a world without polio: the OPV cessation strategy. Biologicals. 2006, 34(2): 75-9.
  • Pallansch MA & Sandhu HS. The eradication of Polio - Progress and Challenges. N Engl J Med 2006, 355: 2508-2511.
  • Sneyers M, Herman P & Moens W. Polio eradication and laboratory containment program of wild polioviruses in Belgium: Laboratory survey and inventory phase. Archives of Public Health 2005, 63 : 57-65.
  • Centers for Disease Control and Prevention (CDC). National laboratory inventory for global poliovirus containment - United States, November 2003. MMWR Morb Mortal Wkly Rep. 2004, 53(21): 457-459.
  • Centers for Disease Control and Prevention (CDC). Global progress toward certifying polio eradication and laboratory containment of wild polioviruses - August 2002-August 2003. MMWR Morb Mortal Wkly Rep. 2003, 52(47):1158-60.
  • Dowdle WR, Gary HE, Sanders R & van Loon AM. Can post-eradication laboratory containment of wild polioviruses be achieved? Bull World Health Organ. 2002, 80(4):311-6.
  • Minor PD. Biosafety consequences of eradication of wild-type polioviruses. Lancet. 2001, 358(9277):166-8.
  • Eichner M & Dietz K. Eradication of poliomyelitis: When can one be sure that Polio virus transmission has been terminated? Am J Epidemiol. 1996, 143 (8): 816-22.